Market closed · After hours · 7:04 PM ET
Last update: Nov 20, 2026, 6:14 PM ET
ResMed Inc.
▼ 9.1% on Oct 30, 2026

Why ResMed Inc. (RMD) Stock Fell 9.1% on Oct 30, 2026

Researched by BestStocks Market Desk · Published Oct 30, 2026
Prior close
$252.83
Oct 30, 2026 close
$229.94
Change
−$22.89
-9.05%
Rel. volume
2.6×
3.4M shares

What happened

Valuation-9.1%high confidence

ResMed beat Q1 fiscal 2027 earnings (non-GAAP EPS $2.91 vs. $2.67–$2.68 expected; revenue $1.41B) and gross margin improved, per Zacks, yet the stock fell 8.26% to $231.95. The decline stems from management's decision to reiterate rather than raise full-year guidance despite the beat, combined with the permanent discontinuation of its Astral 100 and 150 portable ventilator lines due to a circuit board safety issue—creating an estimated $75M revenue headwind (~130 basis points) for fiscal 2027. Volume is elevated at 2.18x the time-adjusted average, signaling intensified selling pressure.

Source: fmp_intraday
What to watch next

Management commentary on the ventilator discontinuation's operational and supply-chain impact during the next earnings call or investor update; Q2 fiscal 2027 results (scheduled 2027-01-28) and whether consensus EPS estimate of $3.03 holds against the revised guidance envelope.

Other developments that session

Filingshigh confidence

ResMed Inc. (RMD) filed its 10-Q on 2026-10-30.

Source: filing_snapshots
News

ResMed beat Q1 FY2027 earnings and revenue estimates while expanding gross margins on strong sleep device demand.

Source: Zacks

Frequently asked questions

Why did ResMed Inc. (RMD) stock fall on Oct 30, 2026?

ResMed beat Q1 fiscal 2027 earnings (non-GAAP EPS $2.91 vs. $2.67–$2.68 expected; revenue $1.41B) and gross margin improved, per Zacks, yet the stock fell 8.26% to $231.95. The decline stems from management's decision to reiterate rather than raise full-year guidance despite the beat, combined with the permanent discontinuation of its Astral 100 and 150 portable ventilator lines due to a circuit board safety issue—creating an estimated $75M revenue headwind (~130 basis points) for fiscal 2027. Volume is elevated at 2.18x the time-adjusted average, signaling intensified selling pressure.

How much did RMD stock fall on Oct 30, 2026?

RMD fell 9.1% during the Oct 30, 2026 trading session.

This is an archived analysis of RMD's Oct 30, 2026 session.
See RMD's latest changes →
Educational research tool — not personalized investment advice. Figures reflect the Oct 30, 2026 session as first analyzed.